DCOY
Decoy Therapeutics Inc.Company with tickers: DCOY
CIK
1615219
CUSIP
79400X503
Shares Outstanding
531,968
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2025-12-30 | HANISH ARNOLD C |
Director | Sell | 12 |
| 2025-12-30 | HANISH ARNOLD C |
Director | Sell | 15 |
| 2025-11-20 | HANISH ARNOLD C |
Director | Other | 12 |
| 2025-11-20 | Rosenblum Mark J |
Exec VP Finance, CFO | Buy | 20,000 |
| 2025-11-20 | HANISH ARNOLD C |
Director | Buy | 5,000 |
| 2025-11-12 | PIERCE FREDERICK II |
Chief Executive Office | Other | 0 |
| 2025-11-12 | Marschel Peter Klaus |
Chief Business Officer | Other | 0 |
| 2025-11-12 | Hibner Barbara Louise |
Chief Scientific Officer | Other | 0 |
| 2025-11-12 | PIERCE FREDERICK II |
Chief Executive Office | Other | 0 |
| 2025-11-12 | PIERCE FREDERICK II |
Chief Executive Office | Other | 16,666 |
| 2025-11-12 | Hibner Barbara Louise |
Chief Scientific Officer | Other | 0 |
| 2025-11-12 | Marschel Peter Klaus |
Chief Business Officer | Other | 0 |
| 2025-11-12 | Marschel Peter Klaus |
Chief Business Officer | Other | 0 |
| 2025-11-12 | PIERCE FREDERICK II |
Chief Executive Office | Other | 0 |
| 2025-11-12 | PIERCE FREDERICK II |
Chief Executive Office | Other | 0 |
| 2025-11-12 | PIERCE FREDERICK II |
Chief Executive Office | Other | 0 |
| 2025-11-12 | Hibner Barbara Louise |
Chief Scientific Officer | Other | 0 |
| 2024-04-11 | Arthur David J. |
Director, Chief Executive Officer | Award | 20,500 |
| 2024-02-20 | McCreedy Bruce J Jr. |
Director | Award | 20,500 |
| 2024-02-20 | Burleson Tess |
Director | Award | 20,500 |
| 2024-02-20 | Rosenblum Mark J |
Exec VP Finance, CFO | Award | 22,500 |
| 2024-02-20 | HANISH ARNOLD C |
Director | Award | 20,500 |
| 2024-02-20 | Lieber Jonathan I |
Chief Financial Officer | Award | 20,500 |
| 2024-02-20 | Lammers Paul |
Director | Award | 20,500 |
| 2024-02-20 | McVicar William K. |
Director | Award | 20,500 |
| 2023-02-13 | Arthur David J. |
Director, Chief Executive Officer | Other | 552 |
| 2023-02-13 | Arthur David J. |
Director, Chief Executive Officer | Other | 564 |
| 2023-02-13 | Arthur David J. |
Director, Chief Executive Officer | Award | 14,300 |
| 2023-02-13 | Rosenblum Mark J |
Exec VP Finance, CFO | Award | 6,432 |
| 2023-01-03 | Arthur David J. |
Director, Chief Executive Officer | Award | 20,000 |
| 2023-01-03 | McVicar William K. |
Director | Other | 1,062 |
| 2023-01-03 | Lammers Paul |
Director | Award | 1,440 |
| 2023-01-03 | Arthur David J. |
Director, Chief Executive Officer | Other | 564 |
| 2023-01-03 | Rosenblum Mark J |
Exec VP Finance, CFO | Award | 8,000 |
| 2023-01-03 | HANISH ARNOLD C |
Director | Other | 1,854 |
| 2023-01-03 | McCreedy Bruce J Jr. |
Director | Award | 1,440 |
| 2023-01-03 | Arthur David J. |
Director, Chief Executive Officer | Other | 552 |
| 2023-01-03 | McVicar William K. |
Director | Award | 1,440 |
| 2023-01-03 | HANISH ARNOLD C |
Director | Award | 1,440 |
| 2023-01-03 | Burleson Tess |
Director | Award | 1,440 |
| 2023-01-03 | Lieber Jonathan I |
Chief Financial Officer | Award | 1,440 |
| 2022-11-03 | Arthur David J. |
Director, Chief Executive Officer | Award | 10,000 |
| 2022-11-03 | Rosenblum Mark J |
Exec VP Finance, CFO | Award | 7,314 |
| 2022-11-03 | Arthur David J. |
Director, Chief Executive Officer | Other | 13,800 |
| 2022-11-03 | Arthur David J. |
Director, Chief Executive Officer | Other | 14,100 |
| 2022-06-07 | Burleson Tess |
Director | Buy | 27,700 |
| 2022-06-07 | Lieber Jonathan I |
Chief Financial Officer | Buy | 37,500 |
| 2022-06-06 | McVicar William K. |
Director | Buy | 26,553 |
| 2022-06-03 | HANISH ARNOLD C |
Director | Buy | 28,000 |
| 2022-05-31 | Rosenblum Mark J |
Exec VP Finance, CFO | Buy | 28,000 |
Showing 1–50 of 115 transactions